Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura Crudi"'
Autor:
Jenny Bulgarelli, Claudia Piccinini, Elisabetta Petracci, Elena Pancisi, Anna Maria Granato, Francesco de Rosa, Massimo Guidoboni, Massimiliano Petrini, Valentina Ancarani, Giovanni Foschi, Antonino Romeo, Luca Tontini, Ugo De Giorgi, Cristian Lolli, Giorgia Gentili, Linda Valmorri, Alice Rossi, Fabio Ferroni, Carla Casadei, Pietro Cortesi, Laura Crudi, Laura Ridolfi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
High-dose interleukin-2 (HD IL-2) has curative potential in metastatic melanoma (MM) and renal cell carcinoma (RCC). Radiotherapy (RT) kills cancer cells and induces immunomodulatory effects. Prospective trials exploring clinical and immunological pr
Externí odkaz:
https://doaj.org/article/a1699934b568420ab4dbf3699d2ce827
Autor:
Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita, Laura Mercatali, Chiara Calabrese, Chiara Spadazzi, Carlo Fabbri, Davide Cavaliere, Riccardo Galassi, Stefano Severi, Maddalena Sansovini, Andreas Tartaglia, Federica Pieri, Laura Crudi, David Bianchini, Domenico Barone, Giovanni Martinelli, Giovanni Luca Frassineti, Toni Ibrahim, Luana Calabrò, Rossana Berardi, Alberto Bongiovanni
Publikováno v:
Cancers, Vol 14, Iss 13, p 3231 (2022)
Neuroendocrine tumors (NETs) are rare neoplasms frequently characterized by an upregulation of the mammalian rapamycin targeting (mTOR) pathway resulting in uncontrolled cell proliferation. The mTOR pathway is also involved in skeletal muscle protein
Externí odkaz:
https://doaj.org/article/7f3b75e701884b91abe69ff61e14830f
Autor:
Stefania Sbaffi, Ilario Giovanni Rapposelli, Silvia Ruscelli, Laura Crudi, Carla Masini, Flavia Pagan, Manlio Monti, Giulia Bartolini, Caterina Donati, Flavia Foca, Alessandro Passardi, Giovanni Luca Frassineti, Laura Matteucci, Francesco Giulio Sullo, Martina Valgiusti
Publikováno v:
Oncologist
Lessons Learned Background The objectives of this study were to compare the safety profiles of sodium levofolinate (Na-Lev) and calcium levofolinate (Ca-Lev) in combination with 5-fluorouracil (5-FU) in the FOLFIRI regimen and to measure the organiza
Autor:
Massimiliano Petrini, Elena Pancisi, Jenny Bulgarelli, Fabio Ferroni, Giorgia Gentili, Elisabetta Petracci, Laura Crudi, Cristian Lolli, Laura Ridolfi, C. Piccinini, Massimo Guidoboni, Francesco Giuseppe De Rosa, Luca Tontini, Linda Valmorri, Alice Rossi, Pietro Cortesi, Antonino Romeo, Carla Casadei, Anna Maria Granato, Giovanni Foschi, Ugo De Giorgi, Valentina Ancarani
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
High-dose interleukin-2 (HD IL-2) has curative potential in metastatic melanoma (MM) and renal cell carcinoma (RCC). Radiotherapy (RT) kills cancer cells and induces immunomodulatory effects. Prospective trials exploring clinical and immunological pr